Francesco Morra
Overview
Explore the profile of Francesco Morra including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
26
Citations
423
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Morra F, Minerva M, Valeggia S, Librizzi G, Tramarin E, Scalpelli C, et al.
Chem Senses
. 2024 Nov;
49.
PMID: 39506900
Transient or persistent hypo-anosmia is common in SARS‑CoV‑2 infection but olfactory pathway late-term morphometric changes are still under investigation. We evaluated late olfactory bulb (OB) imaging changes and their correlates...
2.
Criscuolo D, Morra F, Celetti A
Explor Target Antitumor Ther
. 2022 Nov;
3(5):570-581.
PMID: 36338517
Solute carrier family 7 member 11 (SLC7A11; also known as xCT), a key component of the cystine/glutamate antiporter, is essential for the maintenance of cellular redox status and the regulation...
3.
Morra F, Merolla F, Damia G, Ricci F, Varricchio S, Ilardi G, et al.
J Exp Clin Cancer Res
. 2022 Aug;
41(1):245.
PMID: 35964058
Background: Treatment with PARP inhibitors (PARPi) is primarily effective against high-grade serous ovarian cancers (HGSOC) with BRCA1/2 mutations or other deficiencies in homologous recombination (HR) repair mechanisms. However, resistance to...
4.
Cattarinussi G, Miola A, Trevisan N, Valeggia S, Tramarin E, Mucignat C, et al.
J Affect Disord
. 2022 Jun;
313:36-42.
PMID: 35764231
Background: COVID-19 is an infectious disease that has spread worldwide in 2020, causing a severe pandemic. In addition to respiratory symptoms, neuropsychiatric manifestations are commonly observed, including chronic fatigue, depression,...
5.
Capelli G, Campi C, Bao Q, Morra F, Lacognata C, Zucchetta P, et al.
Nucl Med Commun
. 2022 Apr;
43(7):815-822.
PMID: 35471653
Objective: Reliable markers to predict the response to neoadjuvant chemoradiotherapy (nCRT) in locally advanced rectal cancer (LARC) are lacking. We aimed to assess the ability of 18F-FDG PET/MRI to predict...
6.
Gasparotto M, Puthenparampil M, Morra F, Doria A, Ramonda R
Neurol Sci
. 2022 Apr;
43(7):4103-4105.
PMID: 35362876
No abstract available.
7.
Miro C, Di Giovanni A, Murolo M, Cicatiello A, Nappi A, Sagliocchi S, et al.
Cancer Lett
. 2022 Feb;
532:215581.
PMID: 35134514
Prostate Cancer (PCa) is the most commonly diagnosed non-cutaneous cancer in males and the fifth leading cause of death worldwide. The majority of PCas are androgen-sensitive, with a significant up-regulation...
8.
Morra F, Merolla F, Marino F, Catalano R, Franco R, Chieffi P, et al.
Heliyon
. 2021 Nov;
7(11):e08399.
PMID: 34841108
Coiled-coil domain containing 6 (CCDC6) is a tumour suppressor gene involved in apoptosis and DNA damage response. CCDC6 is known to be functionally impaired upon gene fusions, somatic mutations, and...
9.
Napolitano V, Russo D, Morra F, Merolla F, Varricchio S, Ilardi G, et al.
Cancers (Basel)
. 2021 Aug;
13(15).
PMID: 34359721
Head and neck squamous cell carcinoma (HNSCC) includes a group of aggressive malignancies characterized by the overexpression of the epidermal growth factor receptor (EGFR) in 90% of cases. Neuropilin-1 (NRP-1)...
10.
Liotti F, Marotta M, Sorriento D, Pone E, Morra F, Melillo R, et al.
Cancers (Basel)
. 2021 Feb;
13(4).
PMID: 33578955
Pattern recognition receptors (PRR) promote inflammation but also its resolution. We demonstrated that a specific PRR-formyl peptide receptor 1 (FPR1)-sustains an inflammation resolution response with anti-angiogenic and antitumor potential in...